Andrew Armanino - Dec 18, 2023 Form 4 Insider Report for Better Therapeutics, Inc. (BTTX)

Role
Director
Signature
/s/ Leslie Miller, Attorney-in-fact
Stock symbol
BTTX
Transactions as of
Dec 18, 2023
Transactions value $
$0
Form type
4
Date filed
12/20/2023, 05:22 PM
Previous filing
Nov 2, 2023
Next filing
Feb 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Award $0 +3.75K +28.12% $0.00 17.1K Dec 18, 2023 Direct F1
holding BTTX Common Stock 728K Dec 18, 2023 By Armanino Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting person was awarded 3,750 Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs shall vest on June 1, 2024.
F2 These shares are owned directly by the Andrew J. Armanino III and Denise M. Armanino Family Trust (the "Armanino Trust", and directly by the Reporting Person and his spouse, Denise M. Armanino, as trustees of the Armanino Trust.